Phacoemulsification Combined with Endoscopic Versus Transscleral Cyclophotocoagulation in Poorly Controlled Glaucoma - A Comparative Case Series.
To report medium-term outcomes of a novel combination of phacoemulsification with transscleral cyclophotocoagulation (phaco-TCP) compared to combined phacoemulsification and endoscopic cyclophotocoagulation (phaco-ECP) in patients with uncontrolled or sub-optimally controlled glaucoma and co-existing cataract. Retrospective case series of 80 consecutive patients with minimum 12-months follow-up. 46 eyes underwent phaco-ECP and 34 phaco-TCP.Success was defined as IOP between 6-21▒mmHg with ≥20% reduction from preoperative IOP (with no increase in ocular hypotensive medications or further glaucoma surgery).Secondary outcomes changed in intraocular pressure (IOP), number of ocular hypotensive medications and safety. Mean follow-up was 32.6 ±10.3 months. Pre-operative clinical characteristics were similar in both groups.At latest follow-up, success rate was greater with phaco-TCP than phaco-ECP (67.6% and 47.8%, P=0.037). IOP was also significantly lower after phaco-TCP (14.88 ±5.57▒mmHg, from 22.62±6.52) than phaco-ECP (18.07±6.72▒mmHg, from 22.83±7.88, P=0.0273). Ocular hypotensive medications required reduced similarly after phaco-TCP (from 3.38±0.88 to 2.65±1.04 medications, P=0.0012) and phaco-ECP (from 3.07±0.929 to 2.63±1.42 medications, P=0.0108).There were no cases of hypotony or reduction in vision related to glaucoma or either surgical intervention and a similar proportion required further glaucoma surgery (phaco-ECP 15.2%, phako-TCP 5.9%, P=0.2884). Phaco-TCP appears more successful in controlling IOP than phaco-ECP with similar safety. Further investigation is warranted of this newly proposed combination which may be particularly useful where access or experience with ECP or other minimally invasive glaucoma surgery is limited.